Georgia Students Build CRISPR Lyme Test That Detects Infection in 48 Hours
Teen researchers in suburban Atlanta may have cracked one of diagnostics’ toughest challenges: early Lyme detection. Their CRISPR test shows promise for identifying infection long before standard tools can. For laboratory leaders navigating a rapidly shifting...
New Open-Source Tool Aims to Make Sepsis Prediction Models More Transparent for Clinicians
A new open-source platform enhances the interpretability of CBC-based machine-learning models for sepsis prediction, offering improved transparency and clinical utility. Laboratory leaders watching the evolution of clinical AI tools now have a new development to...
Top 10 Most Influential US Pathologists on Twitter/X Revealed
New ranking highlights the pathologists with the biggest social media reach—and what their influence means for diagnostics, research, and industry engagement. A new analysis identifies the most influential US pathologists on Twitter/X, highlighting a growing link...
Transform Trial Begins: UK’s Largest Prostate Cancer Screening Study Targets Earlier, Safer Diagnosis
With 300,000 men expected to enroll, researchers hope the trial will redefine prostate cancer screening and reduce preventable late-stage disease. The UK has launched the £42 million Transform trial, the largest prostate cancer screening study in decades—marking a...
New Dual-RNA Therapy Takes Aim at KRAS, Cancer’s Toughest Target
Researchers in Singapore unveil a breakthrough RNA strategy that simultaneously silences KRAS mutations and activates immune defenses in hard-to-treat tumors. As precision oncology moves deeper into RNA-based and immune-modulating therapies, clinical laboratories are...
Abbott Moves to Acquire Exact Sciences
Abbott has announced a $21 billion deal to acquire Exact Sciences, which could accelerate early cancer detection, expand at-home testing, and reshape the diagnostics landscape globally. Abbott announced on Nov. 20 that it has entered a definitive agreement to acquire...
At the AMP 2025 Annual Meeting, Hundreds Jam Room to Hear About cfDNA Testing
Association for Molecular Pathology gathering also served up an advocacy push for RESULTS Act passage. The Association for Molecular Pathology (AMP) 2025 Annual Meeting brought together just over 3,000 attendees, and an estimated 420 of them—an impressive 14% of total...
UC San Diego Health Launches First US Blood Test for Testicular Cancer, Setting New Standard for Lab Diagnostics
The CAP- and CLIA-validated microRNA-371a-3P assay promises earlier detection, fewer CT scans, and more precise treatment decisions for a high-risk patient population. According to a press release, UC San Diego Health has become the first health system in the United...
PAMA Reform Gains Momentum: Inside the Fight to Protect Clinical Labs
Congress included lab relief in its latest funding bill, signaling growing awareness of PAMA’s impact. Here’s what lab leaders should do next. During a Nov. 12 webinar hosted by Dark Daily, the discussion centered on why a small laboratory provision ended up in the...
New ADLM Guidelines Give Labs a Roadmap for Accurate Coagulation Testing in DOAC Patients
From test selection to mitigation strategies, the expert panel outlines practical steps to protect result integrity and streamline decision-making. The Association for Diagnostics & Laboratory Medicine (ADLM) has released new expert guidance aimed at helping...
Drug-Resistant Infections Poised to Rise in Europe’s Elderly, Modeling Study Warns
Researchers from the London School of Hygiene and Tropical Medicine project that bloodstream infections caused by resistant bacteria will spike among adults aged 74 and older by 2030. For laboratory leaders, new modeling research underscores a mounting challenge in...
Temporary Delay in PAMA Reductions Provides Labs More Time to Plan
The Senate’s government funding proposal includes a 30-day delay in PAMA cuts, giving clinical labs more time to prepare for reduced Medicare reimbursement rates. Tucked into the Senate’s government funding proposal is a modest yet impactful measure that gives...
IVD Market Consolidates as QIAGEN, Hologic, and Siemens Lead New Wave of M&A
The IVD industry’s consolidation surge continues unabated, as advances in AI-driven genomics and a flurry of private equity deals reshape the sector for a data-driven decade ahead. The in vitro diagnostics (IVD) market is entering a new phase of transformation,...
Shutdown Puts RESULTS Act and Lab Relief on Hold Until Congress Reopens
The bipartisan RESULTS Act, designed to overhaul Medicare’s payment system for clinical laboratory testing, is on hold amid the ongoing government shutdown. With cuts of up to 15% set to hit 800 common lab tests in 2026, laboratory leaders warn that the delay...
Public Trust in CDC Falls to Record Low, Opening Door for Labs to Lead Local Health Response
A new KFF poll shows Americans’ trust in the CDC has dropped to its lowest point since COVID-19, creating an opportunity for clinical laboratories to become trusted local voices in public health. An article from CIDRAP recently reported that public trust in the...
Global AMR Crisis Deepens, WHO Calls on Labs to Strengthen Data and Diagnostics
Drug-resistant infections are outpacing treatments, and WHO says laboratory leaders are vital to protecting antibiotic effectiveness. For laboratory leaders, the latest WHO report on antimicrobial resistance (AMR) underscores just how critical diagnostic testing, data...
Medical Laboratory Personnel Shortage Relief Act Reintroduced to Combat Workforce Crisis
Lawmakers are renewing efforts to tackle the national clinical lab staffing crisis with the reintroduction of the Medical Laboratory Personnel Shortage Relief Act of 2025, a bipartisan bill that would expand training grants and loan forgiveness programs to strengthen...
Infectious Disease Management Gets Big Boost With $37.5m Grant
Seventy-five healthcare systems will benefit from NETEC’s gift, applications open. Infectious disease management is getting a significant lift, on October 15, 2025 the National Emerging Special Pathogens Training and Education Center (NETEC) announced their $37.5m...
Hologic Goes Private in $18.3B Sale to Blackstone and TPG Amid Diagnostics Shake-Up
With Blackstone and TPG acquiring Hologic in an $18.3 billion deal, the IVD industry sees yet another high-value transaction, following the BD-Waters merger and Siemens’ reported divestiture talks. For laboratory leaders, another major consolidation in diagnostics is...
Study Shows Hospitals Can Safely Cut Unnecessary Pre-Surgery Tests
Reducing wasteful pre-op testing doesn’t just save money, it streamlines lab operations and strengthens value-based care. Here’s how Michigan hospitals achieved lasting change. For laboratory leaders, efforts to reduce unnecessary pre-operative testing strike at the...
Extended Government Shutdown Squeezes Clinical Labs as Payment Delays Mount
With the government shutdown now stretching beyond two weeks, clinical laboratory leaders are beginning to feel the pinch. Experts warn that delays in Medicare payments could soon create cash-flow crunches and backlog claims well into November. As the federal...
Diagnostic Billing and Coding Denials Frequently Stem from Three Test Types
Genetic, toxicology, and even routine panels can create pitfalls for clinical laboratories. Clinical laboratory professionals involved with diagnostic billing and coding should double check claims submitted for routine, toxicology, and genetic testing. Those three...
Amazon Tackles Prescription Abandonment, Labs Could Take Note
Amazon Pharmacy kiosks aim to close the gap between prescription and patient. Labs can learn how to reduce delays and improve impact. An alarming number of U.S. prescriptions never make it into patients’ hands. Recent data from a GoodRx survey found that 28% of...
Long COVID in Youth: What Lab Leaders Need to Know About Reinfection Risks
New studies show that children and teens are developing long COVID at higher rates—especially after multiple infections. Here’s how clinical labs can play a vital role in identifying at-risk patients and supporting early intervention. As the healthcare system...
The “Silent Killer” Doesn’t Have to Be Silent: How Laboratory Science Is Changing the Story
Early detection can raise five-year survival rates above 90%, yet most ovarian cancer cases are found late. Emerging biomarker panels and AI-driven tools are empowering labs to make early diagnosis a reality. For clinical laboratories, the fight against ovarian cancer...
-
Sale!
Executive War College 2025 – Audio Recordings
Original price was: $599.00.$399.00Current price is: $399.00. -
ON DEMAND WEBINAR: FDA’s LDT RULE: Steps to Prepare for Your FDA First Milestone Submission
$29.95 -
WEBINAR: FDA’s LDT RULE: Steps to Prepare for Your FDA First Milestone Submission
Price range: $79.95 through $249.00 -
WEBINAR: FDA’s LDT RULE: Understanding What’s Compulsory, What’s Not!
Price range: $79.95 through $249.00 -
Executive War College 2024 – Audio Recordings
$599.00 -
SPECIAL REPORT | Better CLIA Compliance: Reviewing Top Deficiencies from Accreditors and Looking to Future CLIA Reform
$129.00 -
Sale!
SPECIAL REPORT Premium Webinar: Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests
Original price was: $195.00.$79.00Current price is: $79.00. -
DARK DAILY Webinar: What Lab Leaders Need to Know: Data Security Agreements, Surprise Billing, EKRA, AKS, CURES Act, and More
$195.00 -
Audio Recording – Executive War College Presents (2021)
$499.00 -
SPECIAL REPORT: State of the Genetic Testing Marketplace
$195.00